Science Sun Pharm
3004858.803.29% ( +0.28 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Science Sun Pharm(300485) the Revenue is 90.44 M (-2.27%);the EBIT is 9.528 M (+1129%);the EPS is 0.0097 (-88.31%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.09B2.27%
----
----
EBIT
0.01B1128.75%
----
----
EPS
0.009788.31%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf